secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001104659-25-003048
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics receives Nasdaq notice for missing 2024 annual meeting
--------------------------------------------------------------------------

- Notice received Jan 7, 2025 for non-compliance with Nasdaq Listing Rule 5620(a) due to no 2024 annual meeting.
- Company has until Feb 21, 2025 to submit a compliance plan; extension possible to June 30, 2025.
- Intends to hold annual meeting as soon as practicable and will file a proxy statement.
- Notice has no immediate effect on listing or trading of common stock (ENTO).
- Failure to regain compliance may lead to delisting; company can appeal to Nasdaq hearings panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925003048/0001104659-25-003048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925003048/tm252903d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-003048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer